Wave Financial Statements From 2010 to 2024

WVE Stock  USD 14.90  6.34  74.07%   
Wave Life financial statements provide useful quarterly and yearly information to potential Wave Life Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Wave Life financial statements helps investors assess Wave Life's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Wave Life's valuation are summarized below:
Gross Profit
-73.6 M
Profit Margin
(0.67)
Market Capitalization
2.3 B
Enterprise Value Revenue
10.6499
Revenue
110.5 M
There are over one hundred nineteen available fundamental gauges for Wave Life Sciences, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Wave Life's prevalent performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. As of October 17, 2024, Market Cap is expected to decline to about 576.3 M. In addition to that, Enterprise Value is expected to decline to about 414.9 M

Wave Life Total Revenue

118.97 Million

Check Wave Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wave Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.7 M, Interest Expense of 1.8 M or Selling General Administrative of 33.7 M, as well as many indicators such as Price To Sales Ratio of 4.49, Dividend Yield of 0.0 or PTB Ratio of 16.29. Wave financial statements analysis is a perfect complement when working with Wave Life Valuation or Volatility modules.
  
Check out the analysis of Wave Life Correlation against competitors.

Wave Life Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets200.5 M274.9 M147.5 M
Slightly volatile
Short and Long Term Debt Total20.4 M32.1 M15.6 M
Slightly volatile
Other Current Liabilities10.6 M16.8 M7.8 M
Slightly volatile
Total Current Liabilities195.8 M186.4 M64.3 M
Slightly volatile
Other Liabilities96.6 M92 M37.6 M
Slightly volatile
Property Plant And Equipment Net30.2 M35.7 M22.4 M
Slightly volatile
Current Deferred Revenue157.6 M150.1 M44.4 M
Slightly volatile
Accounts Payable8.9 M12.8 M6.5 M
Slightly volatile
Cash140.1 M200.4 M102.9 M
Slightly volatile
Non Current Assets Total42.5 M39.6 M31.5 M
Slightly volatile
Other Assets4.1 M4.3 M8.5 M
Pretty Stable
Cash And Short Term Investments140.1 M200.4 M102.9 M
Slightly volatile
Common Stock Total Equity969.4 M923.3 M385.2 M
Slightly volatile
Common Stock Shares Outstanding111.4 M106.1 M41 M
Slightly volatile
Liabilities And Stockholders Equity200.5 M274.9 M147.5 M
Slightly volatile
Non Current Liabilities Total59 M41 M43.3 M
Slightly volatile
Other Current Assets14.6 M13.9 M5.1 M
Slightly volatile
Total Liabilities132.8 M227.4 M99.4 M
Slightly volatile
Property Plant And Equipment Gross82.4 M78.4 M28.7 M
Slightly volatile
Preferred Stock Total Equity7.4 M9.1 M6.4 M
Slightly volatile
Total Current Assets158 M235.4 M116.1 M
Slightly volatile
Short Term Debt3.6 M6.7 M4.5 M
Slightly volatile
Common Stock481.8 M935.4 M353.5 M
Slightly volatile
Property Plant Equipment22.5 M19.9 M16.7 M
Slightly volatile
Other Stockholder Equity135.7 M129.2 M42.9 M
Slightly volatile
Short and Long Term Debt13.7 K14.4 K43.5 K
Slightly volatile
Warrants6.3 M7.1 M7.7 M
Slightly volatile
Non Currrent Assets Other148.2 K156 K5.3 M
Very volatile
Long Term Debt Total13.7 K14.4 K40.5 K
Slightly volatile
Capital Surpluse144.2 M137.4 M47.1 M
Slightly volatile
Capital Lease Obligations21.5 M32.1 M13.2 M
Slightly volatile
Non Current Liabilities Other135.3 M128.9 M37 M
Slightly volatile
Deferred Long Term Asset Charges413.6 K644 K408.6 K
Slightly volatile
Net Working Capital63.3 M48.9 M102.2 M
Slightly volatile
Long Term Investments40 M45 M49 M
Slightly volatile
Capital Stock751.1 M935.4 M523.3 M
Slightly volatile

Wave Life Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative33.7 M51.3 M25 M
Slightly volatile
Other Operating Expenses127.9 M181.3 M94.5 M
Slightly volatile
Research Development94.2 M130 M69.5 M
Slightly volatile
Total Operating Expenses127 M172.1 M93.8 M
Slightly volatile
Total Other Income Expense Net10.3 M9.8 M3.9 M
Slightly volatile
Cost Of Revenue8.7 M9.2 M45.6 M
Slightly volatile
Interest Income2.2 M1.8 M1.3 M
Slightly volatile
Non Operating Income Net Other1.7 M1.8 MM
Slightly volatile
Reconciled Depreciation8.8 M9.2 M5.3 M
Slightly volatile
Selling And Marketing Expenses7.4 M8.3 MM
Slightly volatile

Wave Life Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow122 M88.5 M89.5 M
Slightly volatile
Depreciation5.8 M9.2 M4.3 M
Slightly volatile
Capital Expenditures1.1 M1.1 M3.1 M
Very volatile
Total Cash From Financing Activities94.8 M132.5 M70.3 M
Slightly volatile
End Period Cash Flow142 M200.4 M104.2 M
Slightly volatile
Sale Purchase Of Stock91.9 M76 M62.8 M
Slightly volatile
Stock Based Compensation12.7 M9.8 M8.6 M
Slightly volatile
Change To Netincome13.5 M19.8 M9.6 M
Slightly volatile
Issuance Of Capital Stock81.9 M131.3 M78.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.494.7288503
Slightly volatile
Days Sales Outstanding58.0861.13153
Pretty Stable
Stock Based Compensation To Revenue0.08210.086411.6685
Slightly volatile
Capex To Depreciation0.120.12111.6364
Very volatile
EV To Sales3.083.24466.843
Pretty Stable
Inventory Turnover16.313.6915.2347
Pretty Stable
Days Of Inventory On Hand0.00.017.2044
Slightly volatile
Payables Turnover0.680.71712.9978
Slightly volatile
Sales General And Administrative To Revenue0.430.452730.138
Slightly volatile
Average Inventory0.40.450.49
Slightly volatile
Research And Ddevelopement To Revenue1.091.147431.3466
Slightly volatile
Capex To Revenue0.00930.00985.5705
Slightly volatile
Cash Per Share1.791.88843.3494
Pretty Stable
Days Payables Outstanding601509443
Very volatile
Income Quality0.320.33790.7501
Slightly volatile
Current Ratio1.21.26255.0558
Very volatile
Receivables Turnover5.084.843.5472
Pretty Stable
Graham Number2.222.33698.6737
Pretty Stable
Capex Per Share0.010.01050.1141
Very volatile
Revenue Per Share1.121.06790.3198
Slightly volatile
Interest Debt Per Share0.30.30270.382
Pretty Stable
Debt To Assets0.110.11681.1722
Slightly volatile
Operating Cycle58.0861.13157
Pretty Stable
Days Of Payables Outstanding601509443
Very volatile
Ebt Per Ebit1.060.85580.9806
Slightly volatile
Quick Ratio1.21.26255.032
Very volatile
Net Income Per E B T0.790.98840.9585
Very volatile
Cash Ratio1.021.07464.8672
Very volatile
Days Of Inventory Outstanding0.00.017.2044
Slightly volatile
Days Of Sales Outstanding58.0861.13153
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.221.05741.0998
Pretty Stable
Fixed Asset Turnover3.333.17190.6216
Slightly volatile
Debt Ratio0.110.11681.1722
Slightly volatile
Price Sales Ratio4.494.7288503
Slightly volatile
Asset Turnover0.430.41210.0851
Slightly volatile

Wave Life Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap576.3 M616.2 M414.7 M
Slightly volatile
Enterprise Value414.9 M422.7 M259.2 M
Slightly volatile

Wave Fundamental Market Drivers

Cash And Short Term Investments200.4 M

Wave Upcoming Events

27th of March 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Wave Life Financial Statements

Wave Life stakeholders use historical fundamental indicators, such as Wave Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although Wave Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in Wave Life's assets and liabilities are reflected in the revenues and expenses on Wave Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Wave Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue150.1 M157.6 M
Total Revenue113.3 M119 M
Cost Of Revenue9.2 M8.7 M
Stock Based Compensation To Revenue 0.09  0.08 
Sales General And Administrative To Revenue 0.45  0.43 
Research And Ddevelopement To Revenue 1.15  1.09 
Capex To Revenue 0.01  0.01 
Revenue Per Share 1.07  1.12 
Ebit Per Revenue(0.60)(0.63)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:
Check out the analysis of Wave Life Correlation against competitors.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.57)
Revenue Per Share
0.929
Quarterly Revenue Growth
(0.11)
Return On Assets
(0.24)
Return On Equity
(19.20)
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.